Provided herein are antibacterial compounds, wherein the compounds in some embodiments have broad spectrum bioactivity. In various embodiments, the compounds act by inhibition of lipoprotein signal peptidase II (LspA), a key protein in bacteria. Pharmaceutical compositions and methods for treatment using the compounds described herein are also provided.
Tanner,D.D.; Van Bostelen,P., Canadian Journal of Chemistry, 1976, vol. 54, p. 2417 - 2425
作者:Tanner,D.D.、Van Bostelen,P.
DOI:——
日期:——
Direct addition of elemental fluorine to double bonds
作者:Shlomo Rozen、Michael Brand
DOI:10.1021/jo00369a011
日期:1986.9
ROZEN SH.; BRAND M., J. ORG. CHEM., 51,(1986) N 19, 3607-3611
作者:ROZEN SH.、 BRAND M.
DOI:——
日期:——
Electrochemical Vicinal Difluorination of Alkenes: Scalable and Amenable to Electron‐Rich Substrates
作者:Sayad Doobary、Alexi T. Sedikides、Henry P. Caldora、Darren L. Poole、Alastair J. J. Lennox
DOI:10.1002/anie.201912119
日期:2020.1.13
oxidative difluorination of alkenes represents an important strategy for their preparation, yet current methods are limited in their alkene-types and tolerance of electron-rich, readily oxidized functionalities, as well as in their safety and scalability. Herein, we report a method for the difluorination of a number of unactivated alkene-types that is tolerant of electron-rich functionality, giving products